A Disintegrin and Metalloproteinase with Thrombospondin Motifs (ADAMTS) is a family of proteolytic enzymes that play crucial roles in the regulation of the extracellular matrix (ECM) and cellular signaling. ADAMTS-8, a specific member of this family, functions primarily in the cleavage of specific substrates within the ECM, thereby affecting processes like cell adhesion, migration, and signaling. Its activity is regulated by various factors, such as protein-protein interactions, substrate availability, and post-translational modifications. In addition, its expression can be modulated by various signaling pathways, including but not limited to, TGF-β, Notch, and PDGF. ADAMTS-8 expression and activity can also be influenced by the cellular microenvironment, including oxidative stress conditions and the availability of various ions and cofactors. Through these interactions, ADAMTS-8 indirectly influences a multitude of physiological processes, ranging from tissue remodeling to cellular differentiation and proliferation.
ADAMTS-8 Activators do not necessarily interact directly with ADAMTS-8 but may exert their effects indirectly by modulating opposing pathways, altering epigenetic regulation, or affecting substrate availability. For example, some of these activators might be inhibitors of pathways that suppress ADAMTS-8 expression, such as TGF-β inhibitors. Others, like HDAC inhibitors, could change the epigenetic landscape favorably for ADAMTS-8 expression. Another approach to activation is through stabilizing the ECM, which serves as the substrate for ADAMTS-8; this could be achieved by molecules that inhibit enzymes responsible for ECM degradation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
As a TGF-β inhibitor, it could potentially upregulate ADAMTS-8 by preventing its downregulation. TGF-β signaling often suppresses ADAMTS-8 expression. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
PDGF Small Molecule Inhibitors could potentially influence ADAMTS activity by interfering with growth factor-mediated ECM remodeling. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
PDGF Small Molecule Inhibitors could potentially influence ADAMTS activity by interfering with growth factor-mediated ECM remodeling. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
This HDAC inhibitor may promote ADAMTS-8 gene expression by altering the epigenetic landscape. | ||||||
Dimethyloxaloylglycine (DMOG) | 89464-63-1 | sc-200755 sc-200755A sc-200755B sc-200755C | 10 mg 50 mg 100 mg 500 mg | $84.00 $301.00 $374.00 $779.00 | 25 | |
This hydroxylase inhibitor could affect post-translational modifications of ADAMTS-8, influencing its stability or activity. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
As a ROS scavenger, it could potentially activate ADAMTS-8 by reducing oxidative stress. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
A gamma-secretase inhibitor that interferes with Notch signaling could indirectly influence ADAMTS-8 expression or activity. | ||||||